SCHEMBL8045464

SCHEMBL8045464

COCN(CCC/C=C\COc1ccc2c(c1)/C(=N/O)c1ccccc1-2)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 2/20 0.42
LMNA P02545 1/20 0.42
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
HTR3A P46098 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
SMARCA2 P51531 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 1/20 0.37
APP P05067 1/20 0.37
SNCA P37840 1/20 0.37
CDK5 Q00535 2/20 0.32
CDK5R1 Q15078 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8040107 0.83 KMT2A (0.44) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8045597 0.79 KMT2A (0.47) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8040097 0.79 KMT2A (0.47) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8051420 0.75 KMT2A (0.50) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8040109 0.73 KMT2A (0.56) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8043998 0.71 MAPT (0.39) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8052590 0.71 MAPT (0.39) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8052438 0.69 KMT2A (0.50) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8046733 0.69 MAPT (0.39) KMT2AMAPTSMN1; SMN2MEN1LMNA
SCHEMBL8053515 0.69 MAPT (0.39) KMT2AMAPTSMN1; SMN2MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085978-A1 BRIDGED CARBOCYCLIC OXIME HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS ENANTA PHARCEUTICALS, INC. (US) 2009-07-09 WO disclosed